Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi.
Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However, the rate of clients opting to self-inject DMPA-SC has remained lower than ea...
Saved in:
Main Authors: | Chelsey Porter Erlank (Author), Gracious Ali (Author), Frehiwot Birhanu (Author), Melinda Stanley (Author), Jessie Salamba Chirwa (Author), Fannie Kachale (Author), Andrews Gunda (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi
by: Gracious Ali, et al.
Published: (2023) -
Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda
by: Philip Anglewicz, et al.
Published: (2019) -
Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
by: Philip Anglewicz, et al.
Published: (2021) -
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
by: Douglas J. Taylor, et al.
Published: (2022) -
The effect of <i>Vigna unguiculata</i> on the estrogen receptor-α expression and the endometrial thickness in rats treated with depot medroxyprogesterone acetate (DMPA)
by: Rizki Fitrianingtyas, et al.
Published: (2023)